How to use Technologies searched

A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.

Selection of 'Enabling Technology, Platform technology' in 'Sector' will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.

Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee.

Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.


Areas of Interest in Platform Technologies at Galderma

Organization name

Galderma business development


Galderma is

  • a global leader in a $13.8 billion global market in developing and commercializing dermatology products
  • dedicated to leading innovation in dermatology 

They have

  • the resources and consider it our priority to maximize your product or technology's potential in dermatology
  • built our product portfolio through successful partnerships and collaborations

Galderma is seeking partnerships in the area of dermatology.

They are seeking to acquire or in-license programs or technologies to support their internal research efforts, such as:

  • Compound libraries
  • Compound library management (purity, concentration, storage, composition, biased libraries)
  • Pathology-oriented cellular assays and in vivo models
  • Validated targets (e.g. GCPR´s, ION channels, enzymes, nuclear receptors)

Galderma is exploring possibilities to also develop and market innovative high-performance products to help in the diagnosis and prognostics of dermatological conditions with the aim to obtain better treatment outcomes. The genomics revolution will stimulate the development of many innovative products based on the identification of new biological markers associated with dermatological diseases. 

Galderma wants to provide a range of diagnostic products and services for the clinical management of dermatologic diseases. Galderma´s area of interest involves medical diagnostic instruments, devices or tests which aid in the diagnosis and prognosis of dermatologic conditions.

They are seeking to license or acquire products or technology in the following areas:

  • Diagnostic assays
  • Prognostic assays
  • Imaging technology

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback

Please click here to log in to view the complete profile.


latest entries